Malek Chamoun
Corporate Officer/Principal presso SUNSHINE BIOPHARMA, INC.
Patrimonio netto: 29 859 $ in data 30/04/2024
Profilo
Malek Chamoun is the founder and current President of Nora Pharma, Inc. which is founded in 2017.
He is currently the Chief Development Officer at Sunshine Biopharma, Inc. where he started in 2024.
Mr. Chamoun received his undergraduate degree from Hautes Etudes Commerciales in 2008.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2024 | 37 000 ( 3.72% ) | 29 859 $ | 30/04/2024 |
Posizioni attive di Malek Chamoun
| Società | Posizione | Inizio |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 25/01/2024 |
Nora Pharma, Inc.
 Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Fondatore | 01/01/2017 |
Formazione di Malek Chamoun
| Hautes Etudes Commerciales | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |
- Borsa valori
- Insiders
- Malek Chamoun
